US Stock MarketDetailed Quotes

Envoy Medical (COCH)

Watchlist
  • 0.6810
  • +0.0010+0.15%
Close May 1 16:00 ET
  • 0.6732
  • -0.0078-1.15%
Post 20:01 ET
52.36MMarket Cap-0.55P/E (TTM)

Envoy Medical (COCH) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-1.40%-18.2M
-11.67%-5.69M
-65.12%-4.33M
4.00%-4.46M
33.35%-3.73M
-5.02%-17.95M
54.32%-5.09M
-338.67%-2.62M
-15.17%-4.65M
-85.62%-5.59M
Net income from continuing operations
-14.24%-23.76M
-42.62%-6.59M
-8.76%-6.48M
-44.16%-5.69M
20.29%-5M
30.50%-20.8M
5.66%-4.62M
-504.89%-5.96M
70.20%-3.95M
52.69%-6.27M
Operating gains losses
-118.22%-127K
155.89%185K
-58.21%308K
99.52%-5K
-146.03%-615K
137.84%697K
80.70%-331K
419.05%737K
---1.05M
1,184.62%1.34M
Depreciation and amortization
74.57%302K
66.67%80K
55.10%76K
102.38%85K
79.41%61K
30.08%173K
0.00%48K
68.97%49K
44.83%42K
25.93%34K
Other non cash items
39.68%2.76M
-2.06%475K
-56.40%623K
474.06%894K
155.15%768K
-85.93%1.98M
-23.26%485K
129.90%1.43M
-102.72%-239K
-96.80%301K
Change In working capital
388.24%1.84M
108.63%78K
-38.55%762K
-66.23%77K
176.71%922K
35.10%-638K
86.49%-904K
-73.00%1.24M
-41.54%228K
-265.56%-1.2M
-Change in receivables
233.74%765K
100.17%1K
133.33%9K
-89.47%2K
2,912.00%753K
-179.02%-572K
-329.93%-589K
50.00%-27K
195.00%19K
316.67%25K
-Change in inventory
133.16%126K
187.41%125K
-154.19%-110K
112.33%37K
152.86%74K
-3,700.00%-380K
-255.43%-143K
287.96%203K
-5,100.00%-300K
---140K
-Change in prepaid assets
-188.89%-8K
112.18%66K
-105.95%-32K
-52.17%33K
-33.93%-75K
101.06%9K
-3,713.33%-542K
176.53%538K
153.91%69K
-51.35%-56K
-Change in payables and accrued expense
955.38%2.22M
342.39%1.04M
-38.14%910K
122.88%70K
120.94%209K
-156.89%-260K
93.54%-427K
-73.62%1.47M
-146.50%-306K
-219.09%-998K
-Change in other current liabilities
-324.42%-1.27M
-244.17%-1.15M
98.41%-15K
-108.71%-65K
-18.18%-39K
251.88%565K
1,832.61%797K
-694.12%-945K
692.06%746K
59.26%-33K
Cash from discontinued investing activities
Operating cash flow
-1.40%-18.2M
-11.67%-5.69M
-65.12%-4.33M
4.00%-4.46M
33.35%-3.73M
-5.02%-17.95M
54.32%-5.09M
-338.67%-2.62M
-15.17%-4.65M
-85.62%-5.59M
Investing cash flow
Cash flow from continuing investing activities
81.73%-179K
-132.21%-172K
0
99.87%-1K
94.50%-6K
-540.52%-980K
2,642.86%534K
-891.94%-615K
-7,081.82%-790K
-84.75%-109K
Net PPE purchase and sale
81.73%-179K
-132.21%-172K
--0
99.87%-1K
94.50%-6K
-540.52%-980K
2,642.86%534K
-891.94%-615K
-7,081.82%-790K
-84.75%-109K
Cash from discontinued investing activities
Investing cash flow
81.73%-179K
-132.21%-172K
--0
99.87%-1K
94.50%-6K
-540.52%-980K
2,642.86%534K
-891.94%-615K
-7,081.82%-790K
-84.75%-109K
Financing cash flow
Cash flow from continuing financing activities
-17.65%16.63M
7.53%6.04M
-56.04%2.6M
98.30%4.44M
-44.69%3.55M
-5.09%20.2M
486.31%5.62M
-62.40%5.92M
-25.40%2.24M
60.65%6.43M
Net issuance payments of debt
-51.93%9.17M
-101.90%-91K
-103.65%-267K
112.87%4.76M
0.51%4.77M
102.23%19.08M
950.27%4.79M
143.87%7.32M
-25.40%2.24M
18.58%4.74M
Net common stock issuance
306.53%7.1M
6,541.27%4.18M
--2.63M
--281K
--0
1,501.83%1.75M
-42.20%63K
--0
--0
--1.68M
Net preferred stock issuance
----
----
----
----
----
--0
--0
----
----
----
Cash dividends paid
25.66%-1.82M
100.16%1K
--0
---607K
---1.21M
---2.45M
---614K
---1.83M
--0
--0
Proceeds from stock option exercised by employees
71.40%3.11M
108.25%2.88M
----
----
----
--1.82M
--1.38M
----
----
----
Net other financing activities
-1.53%-930K
----
----
----
----
-62.70%-916K
----
----
----
----
Cash from discontinued financing activities
Financing cash flow
-17.65%16.63M
7.53%6.04M
-56.04%2.6M
98.30%4.44M
-44.69%3.55M
-5.09%20.2M
486.31%5.62M
-62.40%5.92M
-25.40%2.24M
60.65%6.43M
Net cash flow
Beginning cash position
29.96%5.48M
-19.62%3.56M
202.81%5.29M
7.42%5.31M
29.99%5.48M
2,205.46%4.22M
-73.73%4.42M
2,467.65%1.75M
343.90%4.95M
2,204.92%4.22M
Current changes in cash
-237.67%-1.75M
-82.74%183K
-164.58%-1.73M
99.28%-23K
-124.31%-177K
-68.57%1.27M
108.40%1.06M
-84.03%2.68M
-206.03%-3.2M
-21.72%728K
Effect of exchange rate changes
160.00%3K
--0
0.00%-1K
-100.00%-2K
700.00%6K
-66.67%-5K
0.00%-2K
0.00%-1K
0.00%-1K
-200.00%-1K
End cash Position
-31.81%3.74M
-31.81%3.74M
-19.62%3.56M
202.81%5.29M
7.42%5.31M
29.99%5.48M
29.99%5.48M
-73.73%4.42M
2,467.65%1.75M
343.90%4.95M
Free cash flow
2.90%-18.38M
-28.53%-5.86M
-33.76%-4.33M
17.94%-4.46M
34.52%-3.73M
-9.77%-18.93M
59.19%-4.56M
-412.25%-3.24M
-34.39%-5.44M
-85.60%-5.7M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -1.40%-18.2M-11.67%-5.69M-65.12%-4.33M4.00%-4.46M33.35%-3.73M-5.02%-17.95M54.32%-5.09M-338.67%-2.62M-15.17%-4.65M-85.62%-5.59M
Net income from continuing operations -14.24%-23.76M-42.62%-6.59M-8.76%-6.48M-44.16%-5.69M20.29%-5M30.50%-20.8M5.66%-4.62M-504.89%-5.96M70.20%-3.95M52.69%-6.27M
Operating gains losses -118.22%-127K155.89%185K-58.21%308K99.52%-5K-146.03%-615K137.84%697K80.70%-331K419.05%737K---1.05M1,184.62%1.34M
Depreciation and amortization 74.57%302K66.67%80K55.10%76K102.38%85K79.41%61K30.08%173K0.00%48K68.97%49K44.83%42K25.93%34K
Other non cash items 39.68%2.76M-2.06%475K-56.40%623K474.06%894K155.15%768K-85.93%1.98M-23.26%485K129.90%1.43M-102.72%-239K-96.80%301K
Change In working capital 388.24%1.84M108.63%78K-38.55%762K-66.23%77K176.71%922K35.10%-638K86.49%-904K-73.00%1.24M-41.54%228K-265.56%-1.2M
-Change in receivables 233.74%765K100.17%1K133.33%9K-89.47%2K2,912.00%753K-179.02%-572K-329.93%-589K50.00%-27K195.00%19K316.67%25K
-Change in inventory 133.16%126K187.41%125K-154.19%-110K112.33%37K152.86%74K-3,700.00%-380K-255.43%-143K287.96%203K-5,100.00%-300K---140K
-Change in prepaid assets -188.89%-8K112.18%66K-105.95%-32K-52.17%33K-33.93%-75K101.06%9K-3,713.33%-542K176.53%538K153.91%69K-51.35%-56K
-Change in payables and accrued expense 955.38%2.22M342.39%1.04M-38.14%910K122.88%70K120.94%209K-156.89%-260K93.54%-427K-73.62%1.47M-146.50%-306K-219.09%-998K
-Change in other current liabilities -324.42%-1.27M-244.17%-1.15M98.41%-15K-108.71%-65K-18.18%-39K251.88%565K1,832.61%797K-694.12%-945K692.06%746K59.26%-33K
Cash from discontinued investing activities
Operating cash flow -1.40%-18.2M-11.67%-5.69M-65.12%-4.33M4.00%-4.46M33.35%-3.73M-5.02%-17.95M54.32%-5.09M-338.67%-2.62M-15.17%-4.65M-85.62%-5.59M
Investing cash flow
Cash flow from continuing investing activities 81.73%-179K-132.21%-172K099.87%-1K94.50%-6K-540.52%-980K2,642.86%534K-891.94%-615K-7,081.82%-790K-84.75%-109K
Net PPE purchase and sale 81.73%-179K-132.21%-172K--099.87%-1K94.50%-6K-540.52%-980K2,642.86%534K-891.94%-615K-7,081.82%-790K-84.75%-109K
Cash from discontinued investing activities
Investing cash flow 81.73%-179K-132.21%-172K--099.87%-1K94.50%-6K-540.52%-980K2,642.86%534K-891.94%-615K-7,081.82%-790K-84.75%-109K
Financing cash flow
Cash flow from continuing financing activities -17.65%16.63M7.53%6.04M-56.04%2.6M98.30%4.44M-44.69%3.55M-5.09%20.2M486.31%5.62M-62.40%5.92M-25.40%2.24M60.65%6.43M
Net issuance payments of debt -51.93%9.17M-101.90%-91K-103.65%-267K112.87%4.76M0.51%4.77M102.23%19.08M950.27%4.79M143.87%7.32M-25.40%2.24M18.58%4.74M
Net common stock issuance 306.53%7.1M6,541.27%4.18M--2.63M--281K--01,501.83%1.75M-42.20%63K--0--0--1.68M
Net preferred stock issuance ----------------------0--0------------
Cash dividends paid 25.66%-1.82M100.16%1K--0---607K---1.21M---2.45M---614K---1.83M--0--0
Proceeds from stock option exercised by employees 71.40%3.11M108.25%2.88M--------------1.82M--1.38M------------
Net other financing activities -1.53%-930K-----------------62.70%-916K----------------
Cash from discontinued financing activities
Financing cash flow -17.65%16.63M7.53%6.04M-56.04%2.6M98.30%4.44M-44.69%3.55M-5.09%20.2M486.31%5.62M-62.40%5.92M-25.40%2.24M60.65%6.43M
Net cash flow
Beginning cash position 29.96%5.48M-19.62%3.56M202.81%5.29M7.42%5.31M29.99%5.48M2,205.46%4.22M-73.73%4.42M2,467.65%1.75M343.90%4.95M2,204.92%4.22M
Current changes in cash -237.67%-1.75M-82.74%183K-164.58%-1.73M99.28%-23K-124.31%-177K-68.57%1.27M108.40%1.06M-84.03%2.68M-206.03%-3.2M-21.72%728K
Effect of exchange rate changes 160.00%3K--00.00%-1K-100.00%-2K700.00%6K-66.67%-5K0.00%-2K0.00%-1K0.00%-1K-200.00%-1K
End cash Position -31.81%3.74M-31.81%3.74M-19.62%3.56M202.81%5.29M7.42%5.31M29.99%5.48M29.99%5.48M-73.73%4.42M2,467.65%1.75M343.90%4.95M
Free cash flow 2.90%-18.38M-28.53%-5.86M-33.76%-4.33M17.94%-4.46M34.52%-3.73M-9.77%-18.93M59.19%-4.56M-412.25%-3.24M-34.39%-5.44M-85.60%-5.7M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes--------
Market Insights
China Concept Stocks
View More
Middle East conflict spreads to the stock market! How should investors respond?
On May 1, the more than two-month-long military conflict involving the US, Israel, and Iran will reach a legal milestone, potentially increa Show More